KALA BIO, Inc. (KALA)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about KALA BIO, Inc. (KALA)
Go deeper and ask any question about KALA
Company Performance
Current Price
as of Oct 03, 2024$5.30
P/E Ratio
N/A
Market Cap
$24.42M
Description
KALA BIO, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
Metrics
Overview
- HQArlington, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerKALA
- Price$5.3-1.67%
Trading Information
- Market Cap$24.42M
- Float79.45%
- Average Daily Volume (1m)12,547
- Average Daily Volume (3m)22,538
- EPS-$13.95
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$9.58M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$9.57M
- EV$4.09M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account